| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 35,874 | 32,483 | 24,386 | 47,210 | | Cost of Revenue | 35,597 | 31,079 | 27,768 | 46,381 | | | Gross Profit | 277 | 1,404 | (3,382) | 829 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,426 | 5,780 | 7,726 | 8,165 | | Non Recurring |
-
|
-
| (3,776) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,149) | (4,376) | (7,332) | (7,336) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 36 | 44 | (233) | 710 | | Earnings Before Interest And Taxes | (6,113) | (4,332) | (7,565) | (6,626) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (6,113) | (4,332) | (7,565) | (6,626) | | Income Tax Expense | (2,206) | (1,967) | (2,740) | (2,528) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,907) | (2,365) | (4,825) | (4,098) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,907) | (2,365) | (4,825) | (4,098) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,907) | ($2,365) | ($4,825) | ($4,098) |
|
0.42% Nasdaq 
Income Statement
